The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Quest Diagnostics Inc
SWB:QDI
|
US |
|
Lifenet Insurance Co
OTC:LIFNF
|
JP |
|
B
|
Barratt Redrow PLC
F:3BA
|
UK |
|
R
|
Randstad NV
DUS:RSH
|
NL |
|
MetalQuest Mining Inc
XTSX:MQM
|
CA |
|
U
|
United Utilities Group PLC
XMUN:UUEC
|
UK |
|
T
|
thyssenkrupp AG
XMUN:TKA
|
DE |
|
U
|
United Utilities Group PLC
F:UUEC
|
UK |
|
R
|
Realty Income Corp
LSE:0KUE
|
US |
|
Realty Income Corp
BMV:O
|
US |
|
S
|
Sungmoon Electronics Co Ltd
KRX:014910
|
KR |
|
Zhejiang Juhua Co Ltd
SSE:600160
|
CN |
|
C
|
China Life Insurance Co Ltd
XHAM:CHL
|
CN |
|
J
|
Japan Post Bank Co Ltd
SWB:5JP
|
JP |
|
L
|
Lumentum Holdings Inc
LSE:0JVV
|
US |
|
C
|
China International Capital Corp Ltd
SWB:CIM
|
CN |
|
BAE Systems PLC
LSE:BA
|
UK |
|
Change Financial Ltd
ASX:CCA
|
AU |
|
P
|
Pernod Ricard SA
XMUN:PER
|
FR |
|
U
|
United Utilities Group PLC
DUS:UUEC
|
UK |
|
Novartis AG
SIX:NOVN
|
CH |
|
G
|
General Dynamics Corp
DUS:GDX
|
US |
|
TechnoPro Holdings Inc
F:30T
|
JP |
|
L
|
Lumentum Holdings Inc
DUS:LU2
|
US |
Quest Diagnostics Inc (QDI)’s 12-month stock price forecast through November 2027 has a consensus target of €237.17, implying 5% upside. The forecast is based on price targets from 18 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
QDI is 237.17 EUR with a low forecast of 188.18 EUR and a high forecast of 261.98 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 5%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 9%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 14%.
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 4 years is 13%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more